China DealBook
A Newsletter on Deal Making in China

By: ChinaDesk | May 21, 2017

A Newsletter on Deal Making in China | M&A . Investment Banking .VC . PE . Deals

stada_shanghai_pharma_china_dealbook_m&a_news

Deal News


Shanghai Pharma weighs rival bid for Germany's Stada
Shanghai Pharmaceutical Holding Co Ltd said it may bid for Stada Arzneimittel AG - a move that would pit it against buyout firms Bain and Cinven which have made a joint offer of nearly $6 billion for the German generics drugmaker.

The Chinese company said in a filing it had recently discussed the matter with "a couple of financial investors" but added it had not made a concrete offer and there were still many uncertainties. Shanghai Pharma, which has a market value of $9 billion, needs to submit its bid by June 8 if it wants to challenge an existing 66 euro-a-share bid by Bain and ...

By: ChinaDesk | May 14, 2017

A Newsletter on Deal Making in China | M&A . Investment Banking .VC . PE . Deals

china_deals_2017_m&a_news_newsletter

Deal News


China's $246 Billion Foreign Buying Spree Is Unraveling
After stunning the world with a record $246 billion of announced outbound takeovers in 2016, Chinese dealmakers are now struggling to cope with tighter capital controls and increasingly wary counterparties. Cross-border purchases plunged 67 percent during the first four months of this year, the biggest drop for a comparable period since the depths of the global financial crisis in 2009.


Andre Loesekrug-Pietri, founder and managing partner of A Capital, a private equity fund specializing in Chinese outbound investments, doubts if 2017 could match the $170 billion worth of Chinese investments m...

By: ChinaDesk | May 07, 2017

A Newsletter on Deal Making in China | M&A . Investment Banking .VC . PE . Deals

chemchina_syngenta_m&a_news_china_newsletter_mergers_acquisitions_dealbook_investment_banking

Deal News


ChemChina clinches landmark $43 billion takeover of Syngenta
ChemChina has won more than enough support from Syngenta shareholders to clinch its $43 billion takeover of the Swiss pesticides and seeds group, the two companies said on Friday.

The trend toward market consolidation has triggered fears among farmers that the pipeline for new herbicides and pesticides might slow. Regulators have required some divestments as a condition for approving the Syngenta deal. The other deals in the sector are a $130 billion proposed merger of Dow Chemical and DuPont, and Bayer's plan to merge with Monsanto.


Meanwhile China has conditionally approved the pr...

Category: Daily Newsletter 

Tags: Baidu, Alibaba, IPO, ChemChina, Ant Financial, Anbang, Vanke, Xiaomi, Tencent, Hony Capital, Lufax, SAFE, Didi Chuxing, meituan dianping, Ctrip, Temasek, Bona Filim, Baoneng Group, HNA Group, Santos, Deutsche Bank, PBOC, Syngenta, Matrix Partners China, CRRC, China Renaissance, Fidelity International, CDH Investments, Yingde China, CreditEase, IDG Capital, LeSports, Hillhouse Capital, Foxconn, Yunfeng Capital, MoneyGram, China Oceanwide, Genworth, JD com, PAG Asia Capital, Momo, Sinohydro, MakeMyTrip, CEFC China Energy, Welight Capital, PingAn, CBRC, BGI Genomics, Haier Capital, Zhengzhou Coal Mining, Robert Bosch, COFCO, LongiTech Smart Energy, Belle International, Go-Jek, Tokopedia, Romaco, Truking, Tencent Music, Youon Bike, Haidilao, Jushenghua, China MerchantsSecurities, Nav, Jumei, Ankerbox, Cheetah Mobile, Evolution Media China Gobi Partners, China Rapid Finance, Broadline Capital, Huochebang, Wuxi NextCODE, Congenica, Jin Jiang International, Canaan, Transwrap Technology, China Minsheng Investment Group, Loch Lomond Group, Wu Xiaohui, Robin Li, Shenyang Machine Tool 

By: ChinaDesk | April 22, 2017

A Newsletter on Deal Making in China | M&A . Investment Banking .VC . PE . Deals

li_ka_shing_cki_hk_duet_Australia_m&a_news

Deal News


DUET says Australian government approves $5.5 billion takeover by CKI consortium
Australia's DUET Group on Friday said it had been advised by Cheung Kong Infrastructure Holdings (CKI) that the Australian government has approved the Hong Kong company's $5.5 billion consortium-led takeover offer.

In approving Li Ka-shing's takeover bid for Australia's electricity and gas utility Duet Group, the country's Treasurer Scott Morrison is admitting that the horse on foreign infrastructure investment has already bolted.

 

China's Bitauto raises $1 billion from internet giants Tencent, Baidu
Auto portal Bitauto Holdings Ltd has recently raised $1 bi...

By: ChinaDesk | April 03, 2017

A Newsletter on Deal Making in China | M&A . Investment Banking .VC . PE . Deals

biotest_creat_group_china

Deal News


China's Creat makes 1.2 billion euro bid for German blood plasma firm
Chinese investor Creat Group Corp has offered to buy German blood plasma products maker Biotest for about 1.2 billion euros ($1.3 billion) including debt following its purchase last year of British peer Bio Products Laboratory.


Biotest Chief Executive Bernhard Ehmer told a news conference on Thursday that Creat had not been the only potential bidder to approach Biotest about a deal but it chose to talk to Creat because its proposal was "thought through".


HNA, Apollo Global among bidders vying for HSH Nordbank: sources
Chinese conglomerate HNA Group and Apollo Glob...

next>>